Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment

Terry B. Strom, Loren J. Field, Manfred Ruediger

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

The development of cellular therapies has been seriously hampered by the paucity of cells available for grafting from living or cadaver donors. This sourcing problem can be resolved, at least in theory, by generating tissue-specific cells from autologous or allogeneic stem cells. Nonetheless, there are formidable barriers to the use of stem cells in the clinic. This review focuses on identifying and surmounting these barriers.

Original languageEnglish (US)
Pages (from-to)1133-1139
Number of pages7
JournalJournal of the American Society of Nephrology
Volume15
Issue number5
DOIs
StatePublished - May 2004

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'Allogeneic Stem Cell-Derived "Repair Unit" Therapy and the Barriers to Clinical Deployment'. Together they form a unique fingerprint.

  • Cite this